Please Wait
Applying Filters...
menu
    • menu
    FDA’s December 2025 OPOE list features 784 prescription drugs, 73 OTC drugs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector 2025 highlights: FDA approves pill version of Novo’s Wegovy; BioMarin acquires Amicus for US$ 4.8 bn

    Stock Recap
    #PipelineProspector

    Menu

    Tamsulosin HCl

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 104Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    29/01/2026 Swati Spentose
    India
    		 Samoh Pharmaceutical Co., Ltd. 20230921-209-J-1512 Tamsulosin hydrochloride 2023-09-21 Swati Spentose Private Limited (Unit-I) India Plot No. A-1/2102 & 2103 & A-2/2120, Phase III, GIDC, Vapi - 396 195 Dist : Valsad, Gujarat State India
    29/01/2026 Astellas Pharma
    Japan
    		 Astellas Pharma Korea Co., Ltd. 20210426-209-J-956 Tamsulosin hydrochloride 2021-04-26 Astellas Pharma Inc. Takahagi Technology Center Japan 160-2, Akahama, Takahagi-shi, Ibaraki 318-0001, Japan
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.